Login / Signup

Evaluation of aspirin platelet inhibition in left ventricular assist device population.

Paige Morgan NickelsenJaclyn M HawnHolly MeadowsBrian HoustonRyan J TedfordJohana FajardoCaroline Perez
Published in: Journal of cardiac surgery (2021)
Aspirin responsiveness not only varies between patients but can significantly wane within individual LVAD patients over time. Additional study is needed to determine if monitoring aspirin resistance may prevent thrombotic complications after LVAD implantation.
Keyphrases
  • end stage renal disease
  • left ventricular assist device
  • low dose
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis
  • cardiovascular events
  • type diabetes